Gilead’s IBD drug eliminated symptoms for patients, mid-stage study finds
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
7 trends tracked about this subject — the full history, oldest to newest below.
Gilead's oral drug succeeds in mid-stage ulcerative colitis trials, posting strong remission rates.
1 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Hewlett Packard Enterprise shares hit record highs following a $1.2 billion AI gear order from Vultr and raised growth forecasts.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.